EDIT: Editas Medicine Inc

2.52 USD 0.12 (4.55%)

Settore: Salute Base: US Dollar Valuta di profitto: US Dollar

Il tasso di cambio EDIT ha avuto una variazione del -4.55% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 2.50 e ad un massimo di 2.72.

Segui le dinamiche di Editas Medicine Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.

Grafico a schermo intero

EDIT News

Zacks 21:40 MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
Seeking Alpha 20:57 Editas Medicine - Primed For An Unlikely Comeback? It's Not Impossible
Zacks 13:44 3 Genomics Stocks Worth Adding to Your Portfolio in 2025
The Motley Fool 09:04 Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now?
The Motley Fool 12:15 2 Beaten-Down Stocks to Avoid
Benzinga 17:59 Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst - Eli Lilly (NYSE:LLY), Verve Therapeutics (NASDAQ:VERV)
The Motley Fool 14:07 Editas Medicine Is Great. Here's Why You Shouldn't Buy It.
Investor's Business Daily 13:14 Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
Investing 06:12 Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hema
Investing 20:55 nucana plc announces annual report release and upcoming agm
Investing 21:40 editas medicine amends stock plan and increases authorized shares
The Motley Fool 10:00 1 Stock Down 97% That Could Double, According to Wall Street
Investing 17:59 Chardan cuts Prime Medicine stock target to $12, maintains Buy
Investing 13:50 Cantor maintains Overweight on Astria stock with $47 target
Investing 13:45 Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
Investing 01:03 Editas Medicine at BofA Securities 2025: In Vivo Gene Editing Focus
Seeking Alpha 08:44 CRISPR And Intellia: Balancing Market Uncertainty Against Pipeline Catalysts (NASDAQ:CRSP)
Seeking Alpha 20:07 Editas Medicine, Inc. (EDIT) Barclays 27th Annual Global Healthcare Conference (Transcript)
Seeking Alpha 16:19 Editas Medicine, Inc. (EDIT) Leerink Partners Global Healthcare Conference (Transcript)
Seeking Alpha 22:01 Editas Medicine, Inc. (EDIT) TD Cowen 45th Annual Health Care Conference Transcript

Intervallo Giornaliero

2.50 2.72

Intervallo Annuale

0.91 5.45

Chiusura Precedente: 2.59
Apertura: 2.64

Bid: 2.52
Ask: 2.82

Minimo: 2.50
Massimo: 2.72

Volume: 3.720 K

Variazione giornaliera: -4.55%
Variazione Mensile: 16.67%

Variazione Semestrale: 100.00%
Variazione Annuale: -53.42%

31 luglio, giovedì